SCHEMBL7128189

SCHEMBL7128189

CC(=O)N1CCc2c(c(-c3ccc(Br)cc3)nn2CC(O)CN2CCC(c3c[nH]c4nccc(CCN5CCOCC5)c34)CC2)C1

nearest known ligand 0.56

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CTSS P25774 20/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7117603 0.92 CTSS (0.65) CTSS
SCHEMBL5252335 0.83 CTSS (0.79) CTSS
SCHEMBL7624768 0.82 CTSS (0.72) CTSS
SCHEMBL5251117 0.80 CTSS (0.55) CTSS
SCHEMBL5252121 0.79 CTSS (0.79) CTSS
SCHEMBL5253880 0.77 CTSS (0.61) CTSS
SCHEMBL5251583 0.75 CTSS (0.81) CTSS
SCHEMBL5252728 0.73 CTSS (0.66) CTSS
SCHEMBL5255034 0.72 CTSS (1.00) CTSS
SCHEMBL5256189 0.72 CTSS (0.78) CTSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030229075-A1 Substituted pyrazoles CAI HUI (US) 2003-12-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030229075-A1 Substituted pyrazoles CTSS, CTSZ, CTSV CTSS 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.